The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?
Open accessAbstract
Objective : To estimate by how much and how quickly a given reduction in serum cholesterol concentration will reduce the risk of ischaemic heart disease. Design : Data on the incidence of ischaemic heart disease and serum cholesterol concentration were analysed from 10 prospective (cohort) studies, three international studies in different communities, and 28 randomised controlled trials (with mortality data analysed according to allocated treatment to ensure the avoidance of bias). Main outcome measure - Decrease in incidence of ischaemic heart disease or mortality for a 0.6 mmol/l (about 10%) decrease in serum cholesterol concentration. Results : For men results from the cohort studies showed that a decrease of serum cholesterol concentration of 0.6 mmol/l (about 10%) was associated with a decrease in incidence of ischaemic heart disease of 54% at age 40 years, 39% at age 50, 27% at 60, 20% at 70, and 19% at 80. The combined estimate from the three international studies (for ages 55-64 years) was 38% (95% confidence interval 33% to 42%), somewhat greater than the cohort study estimate of 27%. The reductions in incidence of ischaemic heart disease in the randomised trials (for ages 55-64 years) were 7% (0 to 14%) in the first two years, 22% (15% to 28%) from 2.1-5 years, and 25% (15% to 35%) after five years, the last estimate being lose to the estimate of 27% for the long term reduction from the cohort studies. The data for women are limited but indicate a similar effect. Conclusions - The results from the cohort studies, international comparisons, and clinical trials are remarkably consistent. The cohort studies, based on half a million men and 18 000 ischaemic heart disease events, estimate that a long term reduction in serum cholesterol concentration of 0.6 mmol/l (10%), which can be achieved by moderate dietary change,lowers the risk of ischaemic heart disease by 50% at age 40, falling to 20% at age 70. The randomised trials, based on 45 000 men and 4000 ischaemic heart disease events show that the full effect of the reduction in risk is achieved by five years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610
Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin
Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80293-5 · Cited by 1,824
Clofibrate and Niacin in Coronary Heart Disease
(1975) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1975.03240160024021 · Cited by 1,747
Blankenhorn, D. H. (1987) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1987.03390230069027 · Cited by 1,655
Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-5-786_2 · Cited by 1,418
Martindale. The Extra Pharmacopoeia.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-5-687_2 · Cited by 1,111
Cited by
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
(1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,695
Selected major risk factors and global and regional burden of disease
Ezzati, M., Lopez, A. D., Rodgers, A., Vander Hoorn, S., & Murray, C. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11403-6 · Cited by 3,594
PEDERSEN, T. R. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.027 · Cited by 3,106
Danaei, G., Ding, E. L., Mozaffarian, D., Taylor, B., Rehm, J., Murray, C. J. L., & Ezzati, M. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000058 · Cited by 2,860
Explaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757
Global Burden of Disease and Risk Factors
(2006) · World Bank, Washington, DC eBooks · doi:10.1596/978-0-8213-6262-4 · Cited by 2,605
Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., & Holman, R. R. (1998) · BMJ · doi:10.1136/bmj.316.7134.823 · Cited by 2,014
Interpretation of the evidence for the efficacy and safety of statin therapy
Collins, R., Reith, C., Emberson, J., Armitage, J., Baigent, C., Blackwell, L., Blumenthal, R., Danesh, J., Smith, G. D., DeMets, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31357-5 · Cited by 1,857
Self-citationStimulation of Bone Formation in Vitro and in Rodents by Statins
Mundy, G., Garrett, R., Harris, S., Chan, J., Chen, D., Rossini, G., Boyce, B., Zhao, M., & Gutierrez, G. (1999) · Science · doi:10.1126/science.286.5446.1946 · Cited by 1,774
Law, M. R., Wald, N. J., & Rudnicka, A. R. (2003) · BMJ · doi:10.1136/bmj.326.7404.1423 · Cited by 1,720
Self-citationSurrogate End Points in Clinical Trials: Are We Being Misled?
Fleming, T. R., & DeMets, D. L. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-7-199610010-00011 · Cited by 1,651
A strategy to reduce cardiovascular disease by more than 80%
Wald, N. J., & Law, M. R. (2003) · BMJ · doi:10.1136/bmj.326.7404.1419 · Cited by 1,568
Self-citationPedersen, T. R. (2005) · JAMA · doi:10.1001/jama.294.19.2437 · Cited by 1,548
Grundy, S. M., Cleeman, J. I., Bairey Merz, C. N., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.001 · Cited by 1,550
Controlling the risk of spurious findings from meta-regression
Higgins, J. P. T., & Thompson, S. G. (2004) · Statistics in Medicine · doi:10.1002/sim.1752 · Cited by 1,267
Self-citationWood, D., De Backer, G., Faergeman, O., Graham, I., Mancia, G., & Pyörälä, K. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)90209-x · Cited by 1,255
Prepared by: British Cardiac Society, B. H. S. (2005) · Heart · doi:10.1136/hrt.2005.079988 · Cited by 1,216
(1999) · Clinical and Experimental Hypertension · doi:10.3109/10641969909061028 · Cited by 1,209
Discrepancies between Meta-Analyses and Subsequent Large Randomized, Controlled Trials
LeLorier, J., Grégoire, G., Benhaddad, A., Lapierre, J., & Derderian, F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708213370806 · Cited by 1,171
Second Joint Task Force of European (1998) · European Heart Journal · doi:10.1053/euhj.1998.1243 · Cited by 1,131
Efficacy and Safety of Plant Stanols and Sterols in the Management of Blood Cholesterol Levels
Katan, M. B., Grundy, S. M., Jones, P., Law, M., Miettinen, T., & Paoletti, R. (2003) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)63144-3 · Cited by 1,076
Self-citationSystematic Review: Why sources of heterogeneity in meta-analysis should be investigated
Thompson, S. G. (1994) · BMJ · doi:10.1136/bmj.309.6965.1351 · Cited by 1,017
Kuulasmaa, K., Tunstall-Pedoe, H., Dobson, A., Fortmann, S., Sans, S., Tolonen, H., Evans, A., & Ferrario, M. (2000) · The Lancet · doi:10.1016/s0140-6736(99)11180-2 · Cited by 952
Comparative quantification of health risks conceptual framework and methodological issues
Murray, C. J., Ezzati, M., Lopez, A. D., Rodgers, A., & Vander Hoorn, S. (2003) · Population Health Metrics · doi:10.1186/1478-7954-1-1 · Cited by 887
Kotseva, K., Wood, D., De Backer, G., De Bacquer, D., Pyörälä, K., & Keil, U. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60330-5 · Cited by 833
Mann, S., Beedie, C., & Jimenez, A. (2014) · Sports Medicine · doi:10.1007/s40279-013-0110-5 · Cited by 801
Users' Guides to the Medical Literature: VI. How to Use an Overview
Oxman, A. D. (1994) · JAMA · doi:10.1001/jama.1994.03520170077040 · Cited by 775
Jacobson, T. A., Ito, M. K., Maki, K. C., Orringer, C. E., Bays, H. E., Jones, P. H., McKenney, J. M., Grundy, S. M., Gill, E. A., Wild, R. A., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.02.003 · Cited by 773
Singh, G. M., Danaei, G., Farzadfar, F., Stevens, G. A., Woodward, M., Wormser, D., Kaptoge, S., Whitlock, G., Qiao, Q., Lewington, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065174 · Cited by 772
“This is less of a concern for SBP and TC where there is overwhelming evidence from randomized trials of antihypertensives and cholesterol-lowering drugs that corroborate the evidence from observational studies on causal effects and their magnitude [8,31,32].”
BackgroundHebert, P. R. (1997) · JAMA · doi:10.1001/jama.1997.03550040069040 · Cited by 740
Miettinen, T. A., Puska, P., Gylling, H., Vanhanen, H., & Vartiainen, E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332002 · Cited by 739
Unal, B., Critchley, J. A., & Capewell, S. (2004) · Circulation · doi:10.1161/01.cir.0000118498.35499.b2 · Cited by 739
Plant sterol and stanol margarines and health
Law, M. (2000) · BMJ · doi:10.1136/bmj.320.7238.861 · Cited by 729
Self-citationRisk factors for coronary artery disease: Historical perspectives
Hajar, R. (2017) · Heart Views · doi:10.4103/heartviews.heartviews_106_17 · Cited by 705
Reduction in saturated fat intake for cardiovascular disease
Hooper, L., Martin, N., Abdelhamid, A., & Davey Smith, G. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011737 · Cited by 704
Chronic disability trends in elderly United States populations: 1982–1994
Manton, K. G., Corder, L., & Stallard, E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2593 · Cited by 680
Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible Mechanisms
Levine, G. N., Keaney, J. F., & Vita, J. A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502233320807 · Cited by 672
Pedersen, T. R., Olsson, A. G., Færgeman, O., Kjekshus, J., Wedel, H., Berg, K., Wilhelmsen, L., Haghfelt, T., Thorgeirsson, G., Pyörälä, K., et al. (1998) · Circulation · doi:10.1161/01.cir.97.15.1453 · Cited by 621
Grundy, S. M., Balady, G. J., Criqui, M. H., Fletcher, G., Greenland, P., Hiratzka, L. F., Houston-Miller, N., Kris-Etherton, P., Krumholz, H. M., LaRosa, J., et al. (1998) · Circulation · doi:10.1161/01.cir.97.18.1876 · Cited by 609
Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence
Law, M. R., Morris, J. K., & Wald, N. J. (1997) · BMJ · doi:10.1136/bmj.315.7114.973 · Cited by 604
Self-citationMurray, C. J., Lauer, J. A., Hutubessy, R. C., Niessen, L., Tomijima, N., Rodgers, A., Lawes, C. M., & Evans, D. B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12655-4 · Cited by 599
Davis, B. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(96)00037-4 · Cited by 595
Myasoedova, E., Crowson, C. S., Kremers, H. M., Roger, V. L., Fitz-Gibbon, P. D., Therneau, T. M., & Gabriel, S. E. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.135871 · Cited by 586
Premature cardiovascular disease in chronic renal failure
Baigent, C., Burbury, K., & Wheeler, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02456-9 · Cited by 581
Pietinen, P., Ascherio, A., Korhonen, P., Hartman, A. M., Willett, W. C., Albanes, D., & Virtamo, J. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009047 · Cited by 557
Multiple risk factor interventions for primary prevention of coronary heart disease
Ebrahim, S., Taylor, F., Ward, K., Beswick, A., Burke, M., & Davey Smith, G. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001561.pub3 · Cited by 546
Singh, R. B., Niaz, M. A., Sharma, J. P., Kumar, R., Rastogi, V., & Moshiri, M. (1997) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007757724505 · Cited by 536
Weststrate, J., & Meijer, G. (1998) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600559 · Cited by 536
Jackson, R., Lawes, C. M., Bennett, D. A., Milne, R. J., & Rodgers, A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17833-7 · Cited by 519
Bax, L., Yu, L.-M., Ikeda, N., Tsuruta, H., & Moons, K. G. (2006) · BMC Medical Research Methodology · doi:10.1186/1471-2288-6-50 · Cited by 514
“5 running in Excel 2003) and the reference standard(s) by analyzing eight data sets from meta-analyses that have been published in major journals [4,29-35].”
Seroprevalence, correlates, and characteristics of undetected coeliac disease in England
West, J., Logan, R. F. A., Hill, P. G., Lloyd, A., Lewis, S., Hubbard, R., Reader, R., Holmes, G. K. T., & Khaw, K.-T. (2003) · Gut · doi:10.1136/gut.52.7.960 · Cited by 512
Collins, R., Armitage, J., Parish, S., Sleight, P., & Peto, R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12475-0 · Cited by 492
Lacoste, L., Lam, J. Y. T., Hung, J., Letchacovski, G., Solymoss, C. B., & Waters, D. (1995) · Circulation · doi:10.1161/01.cir.92.11.3172 · Cited by 441
Long-term Intake of Dietary Fiber and Decreased Risk of Coronary Heart Disease Among Women
Wolk, A. (1999) · JAMA · doi:10.1001/jama.281.21.1998 · Cited by 434
Pitt, B., Mancini, G. B. J., Ellis, S. G., Rosman, H. S., Park, J.-S., & Mcgovern, M. E. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00301-0 · Cited by 429
Kontis, V., Mathers, C. D., Rehm, J., Stevens, G. A., Shield, K. D., Bonita, R., Riley, L. M., Poznyak, V., Beaglehole, R., & Ezzati, M. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60616-4 · Cited by 418
A life course approach to diet, nutrition and the prevention of chronic diseases
Darnton-Hill, I., Nishida, C., & James, W. (2004) · Public Health Nutrition · doi:10.1079/phn2003584 · Cited by 418
Pleiotropic Effects of Statins: Benefit Beyond Cholesterol Reduction?
Robinson, J. G., Smith, B., Maheshwari, N., & Schrott, H. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.085 · Cited by 407
Strippoli, G. F. M., Navaneethan, S. D., Johnson, D. W., Perkovic, V., Pellegrini, F., Nicolucci, A., & Craig, J. C. (2008) · BMJ · doi:10.1136/bmj.39472.580984.ae · Cited by 402
Monzani, F., Caraccio, N., Kozàkowà, M., Dardano, A., Vittone, F., Virdis, A., Taddei, S., Palombo, C., & Ferrannini, E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031669 · Cited by 399
Hendriks, H., Weststrate, J., van Vliet, T., & Meijer, G. (1999) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600728 · Cited by 399
Lopez-Huertas, E. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2009.10.007 · Cited by 390
Reduced or modified dietary fat for preventing cardiovascular disease
Hooper, L., Summerbell, C. D., Thompson, R., Sills, D., Roberts, F. G., Moore, H. J., & Davey Smith, G. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002137.pub3 · Cited by 379
Wald, N. J., Watt, H. C., Law, M. R., Weir, D. G., McPartlin, J., & Scott, J. M. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.8.862 · Cited by 369
Self-citationRobinson, J. G., Wang, S., Smith, B. J., & Jacobson, T. A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.024 · Cited by 368
Gaziano, T. A., Young, C. R., Fitzmaurice, G., Atwood, S., & Gaziano, J. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60418-3 · Cited by 366
Bucher, H. C., Guyatt, G. H., Cook, D. J., Holbrook, A., McAlister, F. A., & for the Evidence-Based Medicine Working Group (1999) · JAMA · doi:10.1001/jama.282.8.771 · Cited by 361
Dietary advice for reducing cardiovascular risk
Brunner, E., Thorogood, M., Rees, K., & Hewitt, G. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002128.pub2 · Cited by 351
Costa, J., Borges, M., David, C., & Carneiro, A. V. (2006) · BMJ · doi:10.1136/bmj.38793.468449.ae · Cited by 340
Epidemiology and prevention of clinical and subclinical hypothyroidism.
Vanderpump, M. P. J., & Tunbridge, W. M. G. (2002) · Thyroid · doi:10.1089/105072502761016458 · Cited by 347
Grundy, S. M. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.10.001 · Cited by 347
Infant Feeding and Blood Cholesterol: A Study in Adolescents and a Systematic Review
Owen, C. G., Whincup, P. H., Odoki, K., Gilg, J. A., & Cook, D. G. (2002) · Pediatrics · doi:10.1542/peds.110.3.597 · Cited by 340
Contributions of risk factors and medical care to cardiovascular mortality trends
Ezzati, M., Obermeyer, Z., Tzoulaki, I., Mayosi, B. M., Elliott, P., & Leon, D. A. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.82 · Cited by 338
Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials
Collins, R., & MacMahon, S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03651-5 · Cited by 337
Singhal, A., Cole, T. J., Fewtrell, M., & Lucas, A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16198-9 · Cited by 336
Explaining the Decline in Coronary Heart Disease Mortality in Finland between 1982 and 1997
Laatikainen, T., Critchley, J., Vartiainen, E., Salomaa, V., Ketonen, M., & Capewell, S. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi274 · Cited by 331
Oxidized Low-Density Lipoprotein
Parthasarathy, S., Raghavamenon, A., Garelnabi, M. O., & Santanam, N. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60327-029-8_24 · Cited by 331
Obesity and Disease Management: Effects of Weight Loss on Comorbid Conditions
Anderson, J. W., & Konz, E. C. (2001) · Obesity Research · doi:10.1038/oby.2001.138 · Cited by 330
Reduction in saturated fat intake for cardiovascular disease
Hooper, L., Martin, N., Jimoh, O. F., Kirk, C., Foster, E., & Abdelhamid, A. S. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011737.pub3 · Cited by 330
PYORALA, K., DEBACKER, G., GRAHAM, I., POOLEWILSON, P., & WOOD, D. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90200-3 · Cited by 329
Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy
Law, M., Wald, N., & Morris, J. (2003) · Health Technology Assessment · doi:10.3310/hta7310 · Cited by 327
Self-citationGrundy, S. M., Arai, H., Barter, P., Bersot, T. P., Betteridge, D. J., Carmena, R., Cuevas, A., Davidson, M. H., Genest, J., Kesäniemi, Y. A., et al. (2014) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.12.005 · Cited by 327
Ebrahim, S., & Smith, G. D. (1997) · BMJ · doi:10.1136/bmj.314.7095.1666 · Cited by 315
MacLehose, Reeves, Harvey, Sheldon, Russell, & Black (2000) · Health Technology Assessment · doi:10.3310/hta4340 · Cited by 311
Assessing possible hazards of reducing serum cholesterol
Law, M. R., Thompson, S. G., & Wald, N. J. (1994) · BMJ · doi:10.1136/bmj.308.6925.373 · Cited by 309
Self-citationCapewell, S., Morrison, C. E., & McMurray, J. J. (1999) · Heart · doi:10.1136/hrt.81.4.380 · Cited by 308
Durrington, P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14234-1 · Cited by 307
Bowker, T. J., Clayton, T. C., Ingham, J., McLennan, N. R., Hobson, H. L., Pyke, S. D., Schofield, B., & Wood, D. A. (1996) · Heart · doi:10.1136/hrt.75.4.334 · Cited by 305
Explaining the Increase in Coronary Heart Disease Mortality in Beijing Between 1984 and 1999
Critchley, J., Liu, J., Zhao, D., Wei, W., & Capewell, S. (2004) · Circulation · doi:10.1161/01.cir.0000140668.91896.ae · Cited by 304
Caraccio, N. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.4.1533 · Cited by 301
Dietary fats and coronary heart disease
Willett, W. C. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02553.x · Cited by 297
Masiá, R., Pena, A., Marrugat, J., Sala, J., Vila, J., Pavesi, M., Covas, M., Aubó, C., & Elosua, R. (1998) · Journal of Epidemiology and Community Health · doi:10.1136/jech.52.11.707 · Cited by 296
Healthy dietary habits in relation to social determinants and lifestyle factors
Johansson, L., Thelle, D. S., Solvoll, K., Bjørneboe, G.-E. A., & Drevon, C. A. (1999) · British Journal of Nutrition · doi:10.1017/s0007114599000409 · Cited by 296
Growth Hormone (GH)-Deficient Men Are More Responsive to GH Replacement Therapy Than Women1
Burman, P., Johansson, A. G., Siegbahn, A., Vessby, B., & Karlsson, F. A. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3776 · Cited by 295
Cicero, A. F. G., Colletti, A., Bajraktari, G., Descamps, O., Djuric, D. M., Ezhov, M., Fras, Z., Katsiki, N., Langlois, M., Latkovskis, G., et al. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nux047 · Cited by 295
Ginsberg, H. N., Kris-Etherton, P., Dennis, B., Elmer, P. J., Ershow, A., Lefevre, M., Pearson, T., Roheim, P., Ramakrishnan, R., Reed, R., et al. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.3.441 · Cited by 294
Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy
Grundy, S. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2005 · Cited by 287
Metadata
- Authors
- Law, M. R., Wald, N. J., & Thompson, S. G.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1994-02-05
- Volume
- 308
- Issue
- 6925
- Pages
- 367-372
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2132931461
- Cited by
- 1,210
- References
- 70
- FWCI
- 79.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.